MedPath

Prestilol(Perindopril+Bisoprolol) in Therapy of Patients With Atrial Fibrilation

Conditions
Patient Participation
Registration Number
NCT04484688
Lead Sponsor
Aversi Clinic
Brief Summary

The study aims to evaluate the effectiveness and safety of oral fixed-dose combination of bisoprolol/perindopril in patients with permanent atrial fibrillation

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria

permanent atrial fibrillation with normal EF -

Exclusion Criteria

AF with decreased EF

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
12-ecg and echocardiography evaluation after 1 month treatment1 month
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Aversi Clinic

🇬🇪

Tbilisi, Georgia

© Copyright 2025. All Rights Reserved by MedPath